MINE-ESHAP salvage therapy for recurrent and refractory lymphomas.
Cabanillas
F
F
Lymphoma Section, M.D. Anderson Cancer Center, Houston, TX 77030.
Rodriguez
M A
MA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008223:Lymphoma / Q000188:drug therapy* / Q000401:mortality; D015080:Mesna / Q000008:administration & dosage; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage; D008942:Mitoxantrone / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local; D016879:Salvage Therapy; D015996:Survival Rate
D003561:Cytarabine; D008776:Methylprednisolone Hemisuccinate; D005047:Etoposide; D008942:Mitoxantrone; D015080:Mesna; D002945:Cisplatin; D007069:Ifosfamide